RecallRadar

FDA Drug recall D-1235-2022

Testosterone Cypionate/Enanthate/Propionate 80/80/40mg, a) 5 mL-vial, b) 10 ml-vial, Room temperature, Tailor Made Compounding

On 2022-07-20 the FDA classified a Class II recall of Testosterone Cypionate/Enanthate/Propionate 80/80/40mg, a) 5 mL-vial, b) 10 ml-vial, Room temperature, Tailor Made Compounding by Tmc Acquisition, citing lack of Assurance of Sterility.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1235-2022
ClassificationClass II
Statusongoing
Initiated2022-03-07
Published2022-07-20
Last updated2026-09-13 11:52 UTC
CompanyTmc Acquisition
DistributionUS

Product

Testosterone Cypionate/Enanthate/Propionate 80/80/40mg, a) 5 mL-vial, b) 10 ml-vial, Room temperature, Tailor Made Compounding

Reason

Lack of Assurance of Sterility

Identifiers

code_info
Batch#: a) 10202107A1, Exp 4/18/2022; b) 10142120A2, Exp 4/12/2022; 10272102A1, Exp 4/25/2022 ; 11032117A2, 11102104A2,…Batch#: a) 10202107A1, Exp 4/18/2022; b) 10142120A2, Exp 4/12/2022; 10272102A1, Exp 4/25/2022 ; 11032117A2, 11102104A2, Exp 4/30/2022; 01252212A2 , Exp 7/24/2022; 02182227A1, Exp 8/17/2022 .

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1235-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.